Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples